Editorial: Novel Interventional Targets for Gastrointestinal and Metabolic Disorders

E-ISSN： 1873-4286|23|16|2287-2288

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.16, 2017-06, pp. : 2287-2288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets

By Holzer Peter

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 107-123

Informa Healthcare

Access to resources Recommend Favorite

Gastrointestinal afferents as targets of novel drugs for the treatment of functional bowel disorders and visceral pain

By Holzer P.

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 177-193

Elsevier

Access to resources Recommend Favorite

Activins, Myostatin and Related TGF-&bgr; Family Members as Novel Therapeutic Targets for Endocrine, Metabolic and Immune Disorders

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 2, 2004-06 ,pp. : 157-166

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Epigenetic Targets in Lymphoproliferative Disorders

Current Cancer Drug Targets, Vol. 8, Iss. 5, 2008-08 ,pp. : 378-391

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Neuropeptide Systems as Novel Targets for Psychiatric Disorders (Guest Editor: Guy Griebel) ]

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 2, 2006-04 ,pp. : 133-133

Bentham Science Publishers

Access to resources Recommend Favorite